These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 30900424)

  • 21. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM
    Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.
    Whitworth WC; Goodwin DJ; Racster L; West KB; Chuke SO; Daniels LJ; Campbell BH; Bohanon J; Jaffar AT; Drane W; Sjoberg PA; Mazurek GH
    PLoS One; 2014; 9(1):e86721. PubMed ID: 24466211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
    Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
    Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-Gamma Release Assay Combined with Renal Indicators to Reduce the False-Negativity of Latent Tuberculosis Infection in End-Stage Renal Disease with Hemodialysis Patients.
    Xuan X; Park H; Kang YJ; Jung M; Kim S; Park Y; Lee EJ; Kim YN; Park JY; Chang HK; Kim J; Lim J; Kim S
    Discov Med; 2024 May; 36(184):1002-1011. PubMed ID: 38798259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection.
    Kim SH; Jo KW; Shim TS
    Korean J Intern Med; 2020 Mar; 35(2):383-391. PubMed ID: 31875668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
    Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers.
    Kweon OJ; Lim YK; Kim HR; Kim TH; Lee MK
    J Microbiol Immunol Infect; 2022 Apr; 55(2):328-331. PubMed ID: 34127404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    König Walles J; Tesfaye F; Jansson M; Tolera Balcha T; Winqvist N; Kefeni M; Garoma Abeya S; Belachew F; Sturegård E; Björkman P
    PLoS One; 2018; 13(4):e0193589. PubMed ID: 29617458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.
    Kim OH; Jo KW; Park S; Jo YH; Kim MN; Sung H; Shim TS
    PLoS One; 2020; 15(6):e0234700. PubMed ID: 32544206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion rates of an interferon-γ release assay and the tuberculin skin test in the serial monitoring of healthcare workers.
    Kim SY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
    Infection; 2013 Apr; 41(2):511-6. PubMed ID: 23104257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact.
    Kasambira TS; Shah M; Adrian PV; Holshouser M; Madhi SA; Chaisson RE; Martinson NA; Dorman SE
    Int J Tuberc Lung Dis; 2011 May; 15(5):628-34. PubMed ID: 21756513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.